Bellerophon Therapeutics Inc
(BLPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,977 | 12,940 | 16,900 | 20,780 | 16,746 |
| TOTAL | $10,382 | $13,652 | $17,725 | $21,728 | $17,396 |
| Non-Current Assets | |||||
| PPE Net | 316 | 401 | 488 | 576 | 664 |
| Other Non-Current Assets | 2,410 | 2,556 | 2,365 | 2,489 | 300 |
| TOTAL | $2,726 | $2,957 | $2,853 | $3,065 | $964 |
| Total Assets | $13,108 | $16,609 | $20,578 | $24,793 | $18,360 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,106 | 2,264 | 2,822 | 2,638 | 2,755 |
| Accrued Expenses | 3,820 | 4,069 | 3,332 | 4,072 | 4,784 |
| TOTAL | $7,584 | $6,980 | $6,710 | $7,257 | $7,539 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,933 | 2,280 | 2,406 | 7,231 | 6,965 |
| TOTAL | $1,933 | $2,280 | $2,406 | $7,231 | $6,965 |
| Total Liabilities | $9,517 | $9,260 | $9,116 | $14,488 | $14,504 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,132 | 4,596 | 4,596 | 4,596 | 4,596 |
| Common Shares | 46 | 689 | 689 | 689 | 39 |
| Retained earnings | -189,763 | -185,683 | -181,396 | -177,291 | -176,496 |
| TOTAL | $3,591 | $7,349 | $11,462 | $10,305 | $3,856 |
| Total Liabilities And Equity | $13,108 | $16,609 | $20,578 | $24,793 | $18,360 |